Demo Sign up Log In

AstraZeneca PLC Ordinary Shares (AZN)

Total Costs & Expenses

$12.22B

Quarterly · Period ending: Jun 30, 2026 · USD

AZN Total Costs & Expenses

Latest reported$12.22Bperiod endingJun 30, 2026

Latest reported$12.22Bperiod endingJun 30, 2026

AZN Quarterly Total Costs & Expenses ($1.75B → $12.22B)

Quarterly Total Costs & Expenses

High-resolution chart · PNG

AZN total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Total Costs & Expenses — Quarterly (USD)
Period ending	Total Costs & Expenses (USD)
Jun 30, 2001	3,159,000,000
Mar 31, 2001	2,951,405,458
Dec 31, 2000	5,597,865,970
Sep 30, 2000	2,856,008,041
Jun 30, 2000	3,001,640,818
Mar 31, 2000	2,995,136,381
Dec 31, 1999	5,366,244,402
Sep 30, 1999	3,371,000,000
Jun 30, 1999	3,512,500,000
Mar 31, 1999	4,521,500,000
Dec 31, 1998	1,887,387,218
Sep 30, 1998	2,330,200,000
Jun 30, 1998	2,505,500,000
Mar 31, 1998	2,417,500,000
Dec 31, 1997	2,288,059,340
Sep 30, 1997	2,099,400,000
Jun 30, 1997	2,284,000,000
Mar 31, 1997	2,284,000,000
Dec 31, 1996	4,557,062,756
Sep 30, 1996	2,313,600,000
Jun 30, 1996	2,278,500,000
Mar 31, 1996	2,278,500,000
Dec 31, 1995	1,763,552,932
Sep 30, 1995	1,935,000,000
Jun 30, 1995	1,638,300,000
Mar 31, 1995	2,017,100,000
Dec 31, 1994	1,826,649,215
Sep 30, 1994	1,752,800,000
Jun 30, 1994	1,836,800,000
Mar 31, 1994	1,836,800,000
Dec 31, 1993	1,533,658,718
Sep 30, 1993	1,537,000,000
Jun 30, 1993	1,748,500,000
Mar 31, 1993	1,748,500,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.